TIMI 10A evaluated the pharmacokinetics, safety and efficacy of several doses of TNK-tPA among patients presenting with acute ST elevation myocardial infarction. TIMI 9 Registry assessed management strategies and outcomes of patients presenting with ST elevation myocardial infarction in the era of aggressive reperfusion strategies, who were ineligible for fibrinolytic therapy. TIMI 9B compared the efficacy of a lower dose of intravenous hirudin to unfractionated heparin as adjunctive therapy to fibrinolysis and aspirin among patients presenting with ST elevation myocardial infarction. TIMI 9A compared the safety and efficacy of intravenous hirudin to unfractionated heparin as adjunctive therapy to fibrinolysis and aspirin among patients presenting with ST elevation myocardial infarction. TIMI 8 compared the efficacy of hirulog with unfractionated heparin for the treatment among patients presenting with unstable angina and non-Q-wave myocardial infarction. TIMI 7 evaluated the safety and efficacy of several doses of hirulog in comparison with unfractionated heparin for the treatment of unstable angina. unfractionated heparin in combination with streptokinase for patients with ST elevation myocardial infarction. TIMI 6 compared three doses of hirudin vs. unfractionated heparin in combination with front-loaded tPA for the treatment of patients presenting with ST elevation myocardial infarction. TIMI 5 evaluated the safety and efficacy of several doses of hirudin vs. the combination of reduced dose tPA and APSAC for treatment of patients presenting within 6 hours of onset of ST elevation myocardial infarction. TIMI 4 compared the efficacy of front loaded tPA vs. TIMI 3 Registry was an observational study to enumerate and investigate the natural history and response to treatment of patients presenting with unstable angina and non-Q-wave myocardial infarction. placebo on the culprit coronary lesion in patients with unstable angina or non-Q-wave myocardial infarction. delayed (6 days) metoprolol therapy among patients with ST elevation myocardial infarction treated with rtPA (a substudy of the TIMI II trial). conservative strategy following thrombolysis with rtPA among patients with ST elevation myocardial infarction, and the effect of immediate vs. TIMI 2B compared the effects of an invasive vs. TIMI 2A compared the results of 3 strategies of coronary angiography and angioplasty following intravenous thrombolytic therapy for ST elevation myocardial infarction: immediate invasive, delayed invasive (18-48 h), and a conservative strategy.
#Timi score Activator
TIMI 1 compared the efficacy of tissue plasminogen activator and streptokinase for reperfusion of the infarct-related artery in ST elevation myocardial infarction. Among the group's most important contributions to medicine is the TIMI Risk Score, which assess the risk of death and ischemic events in patients experiencing unstable angina (UA) or a non-ST elevation myocardial infarction (NSTEMI). The group has conducted over 70 practice-changing clinical trials in patients with cardiovascular disease or risk factors for cardiovascular disease. Braunwald held the chairmanship until 2010, when he appointed Marc Sabatine, MD, MPH to the position. The TIMI Study Group was founded by Eugene Braunwald, MD in 1984.
The group has its headquarters in Boston, Massachusetts.
#Timi score trial
The Thrombolysis In Myocardial Infarction, or TIMI Study Group, is an Academic Research Organization (ARO) affiliated with Brigham and Women's Hospital and Harvard Medical School dedicated to advancing the knowledge and care of patients with cardiovascular disease. The TIMI Study Group provides robust expertise in the key aspects of a clinical trial, including academic leadership, global trial management, biostatistics, clinical event adjudication, safety desk, medical hotline, and core laboratories. ( March 2021) ( Learn how and when to remove this template message) The specific problem is: Very long list of trials excessive detail? Excessive deep external linking? Not enough prose context? Please help improve this article if you can. This article may require cleanup to meet Wikipedia's quality standards.
0 kommentar(er)
